Temporal arteritis

M13_TEMPARTERIT

temporal arteritis: Giant cell arteritis (GCA) is a large vessel vasculitis predominantly involving the arteries originating from the aortic arch and especially the extracranial branches of the carotid arteries.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M31.5 Cause of death: ICD-10 — M31.5 2 out of 7 registries used, show all original rules.	1253
4. Check minimum number of events None	1253
5. Include endpoints None	1253
6. Filter based on genotype QC (FinnGen only)	1253

Control definitions (FinnGen only)

Control exclude: M13_SYSTCONNECT

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M31
Name in latin: Arteritis gigantocellularis cum polymyalgia reumatica

NAME	M13_TEMPARTERIT
CONTROL_EXCLUDE	M13_SYSTCONNECT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M315
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M315
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Temporal arteritis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Giant cell arteritis with polymyalgia rheumatica

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	7500	5041	2416
Only index persons	6755	4573	2182
Unadjusted period prevalence (%)
Whole population	0.12	0.14	0.07
Only index persons	0.14	0.17	0.08
Median age at first event (years)
Whole population	72.49	72.98	71.41
Only index persons	71.88	72.38	70.83

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1253	779	474
Unadjusted period prevalence (%)	0.24	0.27	0.21
Median age at first event (years)	69.88	69.52	70.47

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1110: Matched controls
11100

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

PAW37

NOMESCO Finland

Biopsy of temporal artery

905.3

323.0

475

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

4503599627370496.0

323.0

1108

M35.3

ICD-10 Finland

Polymyalgia rheumatica

74.1

323.0

422

H02AB06

ATC

prednisolone; systemic

18.5

307.3

1006

3810

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

6.3

172.1

799

3216

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

10.2

156.7

343

466

M31.6

ICD-10 Finland

Other giant cell arteritis

1668.3

151.7

144

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

8.8

151.6

368

593

M05BA04

ATC

alendronic acid; oral

6.7

123.9

365

753

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

11.4

114.5

228

246

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

19.6

106.2

165

A02BC02

ATC

pantoprazole; systemic

4.5

91.0

934

6006

I77.6

ICD-10 Finland

Arteritis, unspecified

166.9

88.5

M35.1

ICD-10 Finland

Other overlap syndromes

+∞

87.7

R51.80

ICD-10 Finland

Headache

5.2

86.2

311

776

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

6.8

73.9

203

356

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

55.7

672

3984

TPX00

NOMESCO Finland

Biopsy of artery or vein

542.6

52.9

R50.9

ICD-10 Finland

Fever, unspecified

3.7

52.0

266

876

H02AB07

ATC

prednisone; oral

3.4

48.7

277

986

L88

ICPC

Rheumatoid/seropositive arthritis

7.2

44.4

113

173

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.6

43.9

227

744

L04AX01

ATC

azathioprine; systemic

7.3

42.1

105

156

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.0

39.2

276

1119

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

+∞

36.7

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.4

35.8

140

355

M31.3

ICD-10 Finland

Wegener granulomatosis

+∞

34.6

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

+∞

30.3

N01

ICPC

Headache

3.6

29.1

139

419

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

28.7

210

854

AA1AD

NOMESCO Finland

CT of head and brain

2.2

28.7

378

2100

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

40.1

28.2

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.6

27.4

159

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

26.2

406

2401

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

+∞

26.1

G44.2

ICD-10 Finland

Tension-type headache

2.8

25.9

190

773

M05BA07

ATC

risedronic acid; oral

4.2

24.6

251

N02BE01

ATC

paracetamol; systemic, rectal

2.5

24.1

994

8554

J01DB01

ATC

cefalexin; oral

2.1

22.7

902

7463

P01BA02

ATC

hydroxychloroquine; oral

3.2

22.3

124

416

H57.1

ICD-10 Finland

Ocular pain

5.7

22.0

117

M13.9

ICD-10 Finland

Arthritis, unspecified

3.2

21.7

118

392

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

21.4

342

2012

H04.10

ICD-10 Finland

Dry eye syndrome

2.8

21.3

151

597

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.2

21.2

214

ZX120

NOMESCO Finland

Intravenous

2.8

21.2

150

593

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

21.1

289

1594

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

21.1

457

3005

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.0

20.9

130

473

H53.1

ICD-10 Finland

Subjective visual disturbances

3.2

20.9

117

396

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

6.0

20.3

100

M25.5

ICD-10 Finland

Pain in joint

2.0

19.8

321

1887

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

19.4

235

1226

L04AA13

ATC

leflunomide; oral

5.4

18.8

110

A01

ICPC

Pain general/multiple sites

2.7

18.4

131

518

N03AX16

ATC

pregabalin; oral

2.0

18.1

297

1744

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

4.0

18.0

196

R53

ICD-10 Finland

Malaise and fatigue

2.0

17.9

271

1543

M79.6

ICD-10 Finland

Pain in limb

1.8

17.9

438

2954

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

14.1

17.3

M79.1

ICD-10 Finland

Myalgia

2.4

17.3

166

772

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

17.3

145

629

S18

ICPC

Laceration/cut

1.7

17.1

518

3719

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

19.6

16.9

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

6.0

16.8

WX110

NOMESCO Finland

Local anesthesy

1.7

16.6

694

5460

N02AX02

ATC

tramadol; systemic, rectal

1.7

16.4

501

3593

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

16.3

542

3980

M05BX04

ATC

denosumab; parenteral

2.9

16.2

105

390

R06.0

ICD-10 Finland

Dyspnoea

1.8

15.9

333

2118

N03AX12

ATC

gabapentin; oral

2.1

15.9

210

1126

A02BC05

ATC

esomeprazole; systemic

1.7

15.7

472

3354

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

+∞

15.7

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.2

15.6

145

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.0

15.5

313

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

15.3

507

3693

R03AC02

ATC

salbutamol; inhalant

1.7

15.1

551

4117

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.4

15.1

139

631

J01AA02

ATC

doxycycline; systemic

1.8

15.1

852

7217

R51

ICD-10 Finland

Headache

3.4

14.9

225

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

14.8

361

2398

A02BC01

ATC

omeprazole; systemic

1.8

14.8

355

2347

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

14.5

225

1280

H53.2

ICD-10 Finland

Diplopia

4.0

14.2

144

J01FA06

ATC

roxithromycin; oral

1.7

14.1

449

3215

C07AB07

ATC

bisoprolol; oral

1.6

14.0

609

4738

UJF30

NOMESCO Finland

Ileoscopy through colon

2.4

14.0

124

552

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

13.9

467

3388

UJF32

NOMESCO Finland

Coloscopy

1.7

13.8

330

2167

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

+∞

13.6

M54.5

ICD-10 Finland

Low back pain

1.7

13.5

344

2300

H34.1

ICD-10 Finland

Central retinal artery occlusion

11.1

13.5

J01FA10

ATC

azithromycin; systemic

1.6

13.4

547

4166

R51.81

ICD-10 Finland

Facial pain NOS

4.9

13.4

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

13.3

161

827

J01FF01

ATC

clindamycin; systemic

1.7

13.1

303

1966

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

13.1

250

1525

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

13.1

391

2736

L28

ICPC

Limited function/disability (L)

1.9

13.0

227

1346

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.6

13.0

408

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

12.9

337

2263

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

12.9

401

2829

J01CA04

ATC

amoxicillin; systemic

1.7

12.7

825

7038

M03BX02

ATC

tizanidine; oral

1.6

12.7

608

4794

L17

ICPC

Foot/toe symptom/complaint

1.7

12.7

303

1983

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.5

12.6

100

421

L04AC07

ATC

tocilizumab; parenteral

32.4

12.6

M31.1

ICD-10 Finland

Thrombotic microangiopathy

+∞

12.5

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

12.5

123

578

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

12.4

114

515

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.9

12.4

267

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

12.3

394

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.4

12.3

105

457

H53.9

ICD-10 Finland

Visual disturbance, unspecified

3.6

12.2

154

A03

ICPC

Fever

2.1

12.2

143

726

XCK00

NOMESCO Finland

Perimetry

2.3

12.2

111

502

A02BC03

ATC

lansoprazole; oral

1.7

12.2

358

2481

TAB00

NOMESCO Finland

Lumbar puncture

3.4

12.2

181

A04

ICPC

Weakness/tiredness general

2.0

11.7

167

917

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

12.7

11.6

M79.7

ICD-10 Finland

Fibromyalgia

4.1

11.6

110

H53.4

ICD-10 Finland

Visual field defects

4.6

11.5

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

11.5

244

1532

M30.0

ICD-10 Finland

Polyarteritis nodosa

+∞

11.5

SPAT1263

SPAT

Sampling

1.6

11.4

470

3537

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

11.3

178

1014

J01MA02

ATC

ciprofloxacin; systemic

1.6

11.3

442

3284

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.8

11.2

206

1236

R05

ICD-10 Finland

Cough

1.8

11.1

219

1345

H26.3

ICD-10 Finland

Drug-induced cataract

11.3

11.1

5BA08

NOMESCO Finland

10.2

11.0

SPAT1153

SPAT

Removal of sutures

1.6

11.0

391

2828

R52.9

ICD-10 Finland

Pain, unspecified

2.3

11.0

105

484

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

11.0

163

908

C03CA01

ATC

furosemide; systemic

1.6

10.9

410

3007

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

10.9

479

3649

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

10.9

421

N05CF01

ATC

zopiclone; oral

1.6

10.8

387

2804

L04AA06

ATC

mycophenolic acid; systemic

6.2

10.8

J01MA12

ATC

levofloxacin; systemic

1.8

10.7

225

1406

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

10.7

100

456

E0000UV

ATC

1.6

10.5

414

3066

M31.0

ICD-10 Finland

Hypersensitivity angiitis

+∞

10.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

10.4

106

506

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.5

10.4

143

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

10.3

217

1358

H02AB09

ATC

hydrocortisone; systemic

4.8

10.2

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.7

10.0

A07EC01

ATC

sulfasalazine; oral, rectal

2.3

10.0

443

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

10.0

141

769

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

10.0

131

693

R02

ICPC

Shortness of breath/dyspnoea

1.9

10.0

157

890

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

10.0

354

2551

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

9.9

260

1731

J01MA14

ATC

moxifloxacin; systemic

2.1

9.9

111

551

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

9.8

259

1728

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

9.7

470

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

9.6

183

1108

G50.1

ICD-10 Finland

Atypical facial pain

4.4

9.6

A46

ICD-10 Finland

Erysipelas

1.8

9.5

174

1039

M31.4

ICD-10 Finland

Aortic arch syndrome [Takayasu]

+∞

9.4

4AC0X

NOMESCO Finland

+∞

9.4

L01AA01

ATC

cyclophosphamide; systemic

12.5

9.4

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.1

9.3

103

507

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

9.3

141

789

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

13.8

9.2

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

9.1

100

493

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

11.6

9.1

H47.1

ICD-10 Finland

Papilloedema, unspecified

15.7

9.0

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

9.0

118

626

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

9.0

140

788

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

9.0

190

1185

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

8.8

209

1351

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

8.7

127

699

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

8.7

164

988

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

6.7

8.7

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

8.6

413

SPAT1301

SPAT

No procedures

1.5

8.6

365

2719

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.4

8.6

116

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.4

8.5

296

JN4BD

NOMESCO Finland

Extensive body CT

1.8

8.5

140

807

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

8.4

644

5408

R52.2

ICD-10 Finland

Other chronic pain

3.1

8.4

145

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

8.4

101

517

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

8.4

107

563

G47.3

ICD-10 Finland

Sleep apnoea

1.7

8.3

196

1258

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

+∞

8.3

4AC07

NOMESCO Finland

+∞

8.3

M31.7

ICD-10 Finland

Microscopic polyangiitis

+∞

8.3

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

4.2

8.3

L03

ICPC

Low back symptom/complaint

1.6

8.3

253

1744

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

8.3

327

M01AE02

ATC

naproxen; oral, rectal

1.4

8.3

545

4436

H02AB04

ATC

methylprednisolone; systemic

1.7

8.3

169

1042

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

8.2

169

1045

L01

ICPC

Neck symptom/complaint

1.8

8.2

146

862

A02BA02

ATC

ranitidine; systemic

1.6

8.2

242

1650

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

8.2

164

1007

R20.2

ICD-10 Finland

Paraesthesia of skin

2.4

8.2

313

Z00.0

ICD-10 Finland

General medical examination

1.7

8.1

200

1299

L95

ICPC

Osteoporosis

2.6

8.1

227

R03BB04

ATC

tiotropium bromide; inhalant

1.9

8.1

126

713

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.0

8.1

512

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

8.1

297

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

8.0

123

689

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

8.0

433

3385

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

7.9

507

4094

R63.4

ICD-10 Finland

Abnormal weight loss

2.7

7.9

193

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.9

7.9

111

604

NXL00

NOMESCO Finland

Biopsy of muscle

13.1

7.9

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

7.9

175

1107

H46

ICD-10 Finland

Optic neuritis

8.5

7.8

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

7.8

186

1201

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

7.7

161

997

M05.2

ICD-10 Finland

Rheumatoid vasculitis

45.3

7.7

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.6

7.7

R42

ICD-10 Finland

Dizziness and giddiness

1.5

7.7

269

1910

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.1

7.7

448

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.8

7.7

167

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

7.7

712

6150

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

7.6

209

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

7.6

308

2259

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

7.6

139

830

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

4.3

7.5

WZA90

NOMESCO Finland

Other doctors statement

1.6

7.5

213

1436

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.9

7.5

H15.1

ICD-10 Finland

Episcleritis

4.5

7.5

R03DC03

ATC

montelukast; oral

1.7

7.5

154

953

M01AH03

ATC

valdecoxib; oral

2.1

7.5

385

PAA99

NOMESCO Finland

Exploration of other arterial branch originating from aortic arch arteries

80.6

7.4

CS494

NOMESCO Finland

Other visual field testing

3.0

7.4

136

H26.4

ICD-10 Finland

After-cataract

1.7

7.4

145

882

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.8

7.4

166

R05

ICPC

Cough

1.6

7.3

226

1555

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.9

7.3

154

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.6

7.3

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

+∞

7.3

4AC0L

NOMESCO Finland

+∞

7.3

J02AC01

ATC

fluconazole; systemic

1.5

7.3

370

2842

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

7.3

174

1122

C08CA01

ATC

amlodipine; oral

1.4

7.3

447

3562

B02.9

ICD-10 Finland

Zoster without complication

2.1

7.2

375

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.2

7.2

116

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

7.1

409

3215

L08

ICPC

Shoulder symptom/complaint

1.6

7.0

205

1392

B01AF02

ATC

apixaban; oral

1.7

7.0

134

809

R60.0

ICD-10 Finland

Localized oedema

1.7

7.0

135

817

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

7.0

430

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

6.9

405

SPAT1310

SPAT

Counselling related to known health issue

1.5

6.9

337

2562

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

6.9

247

1757

M81.4

ICD-10 Finland

Drug-induced osteoporosis

13.9

6.9

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.8

6.9

149

N06AA09

ATC

amitriptyline; systemic

1.8

6.9

114

660

J05AB01

ATC

aciclovir; systemic

1.6

6.9

213

1469

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.5

6.9

217

R07.3

ICD-10 Finland

Other chest pain

1.8

6.8

108

612

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

6.8

190

1274

B01AC04

ATC

clopidogrel; oral

1.6

6.8

204

1391

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

6.8

181

1202

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

6.8

405

3198

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

6.7

209

1440

J37.0

ICD-10 Finland

Chronic laryngitis

2.8

6.7

145

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

6.7

167

1090

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.8

6.7

L60.0

ICD-10 Finland

Ingrowing nail

2.5

6.7

195

F29

ICPC

Eye symptom/complaint other

1.9

6.7

514

K04.1

ICD-10 Finland

Necrosis of pulp

2.0

6.7

469

ZXA00

NOMESCO Finland

Right side

1.4

6.7

319

2415

R01AD01

ATC

beclometasone; nasal

1.7

6.6

151

961

R01AD08

ATC

fluticasone; nasal

1.5

6.6

250

1803

R01AD09

ATC

mometasone; nasal

1.4

6.5

401

3179

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.6

6.5

173

D07AC01

ATC

betamethasone; topical

1.4

6.5

339

2605

C01CA24

ATC

epinephrine; parenteral

2.5

6.5

202

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

6.5

100

564

M05BA06

ATC

ibandronic acid; systemic

2.8

6.5

137

SPAT1254

SPAT

Administration of medicine

1.6

6.4

167

1101

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.3

6.4

Z71.8

ICD-10 Finland

Other specified counselling

1.5

6.4

223

1578

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

6.4

113

665

R06AE07

ATC

cetirizine; oral

1.4

6.4

407

3246

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

6.4

283

2106

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

6.4

207

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.4

6.4

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

6.6

6.3

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.5

6.3

181

R04.2

ICD-10 Finland

Haemoptysis

2.5

6.3

181

PD5BD

NOMESCO Finland

Extensive CT of aorta

3.1

6.3

105

R03BA02

ATC

budesonide; inhalant

1.6

6.3

173

1153

C08CA05

ATC

nifedipine; systemic

2.0

6.3

428

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

+∞

6.3

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

+∞

6.3

S97

ICPC

Chronic ulcer skin

2.0

6.2

373

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

7.1

6.2

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

4.1

6.2

JN4AD

NOMESCO Finland

Body CT examination

1.9

6.2

482

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.3

6.1

248

M01AH02

ATC

rofecoxib; oral

1.6

6.1

164

1088

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

6.1

306

J01FA09

ATC

clarithromycin; systemic

1.4

6.1

291

2195

J01DA01

ATC

[U] cefalexin; systemic

1.4

6.1

631

5445

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.4

6.0

211

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.2

6.0

264

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

477

1062

6.64

219.33

1.6

1.2

titre

572.5

395.4

1.16

106

233

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

256

300

10.47

208.44

2.2

1.5

titre

295.0

174.5

0.33

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

209

261

9.41

160.58

1.7

1.6

iu/ml

0.1

0.20

(3001604) Monocytes [#/volume] in Blood

958

5020

4.86

134.55

12.1

5.1

e9/l

0.6

3.93

879

4240

(3006315) Basophils [#/volume] in Blood

960

5039

4.87

134.50

12.2

5.1

e9/l

0.0

0.51

880

4274

(3013115) Eosinophils [#/volume] in Blood

976

5213

4.95

132.83

12.3

5.3

e9/l

0.2

11.20

898

4486

(3019198) Lymphocytes [#/volume] in Blood

964

5132

4.81

130.97

12.2

5.2

e9/l

1.8

1.9

0.35

894

4428

(3022096) Basophils/100 leukocytes in Blood

877

4617

4.00

114.51

12.6

5.3

0.6

0.7

3.66

847

4249

(3019069) Monocytes/100 leukocytes in Blood

890

4757

4.01

112.97

13.0

5.6

8.4

8.9

4.12

861

4383

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

162

225

8.12

112.92

1.8

1.1

g/l

0.2

0.34

150

209

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

163

234

7.86

110.34

1.8

1.2

g/l

1.3

1.2

2.01

153

218

(3006504) Eosinophils/100 leukocytes in Blood

883

4741

3.92

110.21

12.7

5.3

2.1

2.8

26.86

855

4354

(3002030) Lymphocytes/100 leukocytes in Blood

890

4848

3.89

107.61

12.8

5.6

24.3

26.4

7.60

860

4443

(3004588) Protein electrophoresis panel - Serum or Plasma

311

838

4.61

107.36

1.6

2.8

—

(3018010) Neutrophils/100 leukocytes in Blood

875

4767

3.77

104.53

12.4

5.3

62.1

58.3

15.88

843

4393

(42870588) Differential panel, method unspecified - Blood

722

3550

3.44

100.35

11.0

5.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

994

5979

4.20

100.04

14.8

8.6

e9/l

5.0

4.2

22.60

915

5175

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

419

1471

3.78

99.47

1.4

1.2

iu/ml

33.2

43.5

0.82

131

453

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

124

150

9.06

96.52

1.9

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

406

1421

3.75

96.45

1.4

1.2

u/ml

7.7

14.3

1.24

132

490

(3015171) Extractable nuclear Ab [Units/volume] in Serum

165

279

6.66

95.64

1.4

1.1

u/ml

0.2

1.4

0.78

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

153

241

7.09

94.88

2.3

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

967

5836

3.88

93.80

7.9

6.4

mmol/l

1.2

1.30

855

4905

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

816

4463

3.38

92.26

3.0

2.2

nmol/l

82.3

79.9

1.45

759

3861

(3020630) Protein [Mass/volume] in Serum or Plasma

323

1025

3.90

87.78

1.7

3.0

g/l

65.1

66.1

1.37

292

919

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

682

3454

3.14

86.10

2.8

2.1

u/l

113.6

236.8

5.02

646

3209

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

882

5321

3.22

79.06

6.6

5.7

mmol/l

1.2

0.37

849

4756

(3036481) Cortisol [Moles/volume] in Serum or Plasma

288

920

3.77

76.63

2.2

2.0

nmol/l

339.0

385.3

3.49

260

824

(3013707) Erythrocyte sedimentation rate by Westergren method

1099

7776

4.36

72.09

15.7

3.9

mm/h

17.1

14.4

5.59

1063

7040

(46235355) HIV 1 and 2 tests - Meaningful Use set

265

887

3.52

64.87

1.4

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

239

774

3.58

61.33

1.4

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

242

803

3.50

59.70

7.3

3.4

0.5

0.14

186

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

243

815

3.46

58.90

1.4

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

146

343

4.69

58.19

1.5

2.8

g/l

0.0

0.95

129

313

(3017181) Myelocytes/100 leukocytes in Blood

256

895

3.34

58.00

7.9

3.6

0.9

0.14

100

260

(3021440) Promyelocytes/100 leukocytes in Blood

246

844

3.38

57.41

8.1

3.6

0.0

0.1

1.87

235

(3005719) IgG [Mass/volume] in Serum or Plasma

220

706

3.57

57.00

2.5

2.8

g/l

10.2

10.9

0.81

199

636

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

470

4.08

56.25

1.5

2.8

g/l

3.9

3.7

0.63

129

327

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

471

4.07

56.08

1.5

2.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

471

4.07

56.08

1.5

2.8

g/l

8.8

7.5

9.32

132

343

(3037467) Urinalysis macro (dipstick) panel - Urine

1029

7421

3.16

55.76

8.6

4.7

—

(3023368) Bacteria identified in Blood by Culture

593

3302

2.51

54.74

5.1

4.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

163

437

4.14

54.65

1.5

2.9

g/l

3.9

3.1

8.47

130

335

(3018418) pH of Serum or Plasma

617

3503

2.50

54.55

4.4

3.9

7.4

0.24

127

660

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

161

439

4.06

52.69

1.5

2.9

g/l

9.4

10.3

1.67

138

365

(3028026) IgM [Mass/volume] in Serum or Plasma

185

558

3.72

52.41

1.6

1.8

g/l

1.2

1.5

0.72

168

499

(3025159) Blasts/100 leukocytes in Blood

226

785

3.29

51.33

8.5

3.6

0.0

0.5

0.55

201

(3021879) Hepatitis B virus core Ab [Presence] in Serum

172

502

3.81

51.08

1.2

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

149

393

4.17

50.96

1.5

1.9

u/l

33.4

38.7

2.77

133

339

(40760892) CBC W Ordered Manual Differential panel - Blood

409

1981

2.58

49.91

9.2

4.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

150

406

4.06

49.49

1.7

3.0

g/l

0.3

1.6

3.90

131

344

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

131

321

4.44

49.32

1.5

2.9

g/l

0.0

0.00

115

296

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

131

324

4.40

48.72

1.5

2.8

g/l

0.0

0.00

115

296

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1086

8321

3.29

47.93

13.1

7.4

u/l

72.5

80.2

8.31

1060

7727

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

139

369

4.11

47.03

1.5

2.7

g/l

32.9

37.5

11.08

117

309

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

148

5.94

45.01

1.4

1.1

u/ml

3.1

13.7

—

(3021589) Normoblasts [#/volume] in Blood

700

4517

2.25

42.35

17.7

9.9

e9/l

0.0

0.38

605

3671

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

187

5.11

41.28

1.5

1.1

u/ml

8.2

3.3

0.90

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

192

5.03

41.00

1.6

1.1

u/ml

15.7

3.9

0.99

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

8.60

40.93

1.4

1.1

titre

185.0

67.5

0.56

(3009261) Glucose [Presence] in Urine by Test strip

766

5219

2.20

39.26

6.2

4.2

estimate

0.0

0.50

183

927

(3035350) Ketones [Presence] in Urine by Test strip

756

5137

2.19

38.84

6.2

4.2

estimate

0.0

0.00

180

944

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

642

4100

2.16

38.62

4.3

3.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

103

253

4.35

38.49

1.5

2.0

mg/l

10.2

12.1

1.81

231

(3013826) Glucose [Moles/volume] in Serum or Plasma

893

6516

2.29

37.98

5.7

4.7

mmol/l

6.7

6.8

1.09

859

6124

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

512

3011

2.18

37.85

2.7

2.2

mg/l

3.2

0.10

442

2507

(3021601) Nitrite [Presence] in Urine by Test strip

750

5160

2.13

36.26

8.0

5.7

estimate

0.0

0.00

185

931

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

146

492

3.23

34.25

1.7

1.8

ug/l

1.1

2.0

0.62

122

420

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

130

408

3.44

34.20

1.6

3.8

ratio

2.0

1.7

0.11

(3037756) Immunofixation for Serum or Plasma

104

282

3.93

33.96

1.3

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

131

420

3.37

33.30

1.7

3.8

mg/l

30.1

89.2

1.19

103

349

(3034860) Kappa light chains.free [Mass/volume] in Serum

131

420

3.37

33.30

1.7

3.8

mg/l

40.3

65.4

0.97

102

347

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

371

2011

2.20

32.79

2.2

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

952

7332

2.24

32.48

6.8

5.1

e6/l

188.0

2297.0

—

127

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

9.33

32.25

1.2

1.1

u/l

5.3

5.2

0.03

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

278

1360

2.34

31.27

2.9

3.8

u/l

239.8

250.7

0.45

258

1277

(3024980) IgG subclass 4 [Mass/volume] in Serum

122

5.38

31.21

1.4

1.6

g/l

0.8

0.01

(3001122) Ferritin [Mass/volume] in Serum or Plasma

627

4202

1.99

30.61

3.4

2.7

ug/l

176.8

137.7

1.80

571

3766

(3018095) Leukocytes [#/volume] in Urine

603

3990

1.99

30.52

5.1

3.9

e6/l

90.1

112.7

0.34

463

2891

(40758558) Short blood count panel - Blood

441

2628

2.05

29.89

9.8

6.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

324

1720

2.19

29.77

1.5

1.4

g/l

2.4

2.6

0.42

217

968

(3022948) Iron [Moles/volume] in Serum or Plasma

334

1808

2.16

29.13

2.6

2.4

umol/l

11.3

12.2

1.28

307

1656

(40760888) Immunoglobulin light chains.free panel - Serum

102

303

3.58

29.12

1.6

4.1

—

(3004616) Nuclear Ab [Presence] in Serum

5.78

28.51

1.5

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

169

4.46

28.44

2.5

5.2

iu/ml

367.3

450.1

—

(3030467) Casts [#/volume] in Urine by Automated count

504

3203

1.96

28.03

3.8

3.2

e6/l

0.3

0.5

2.68

412

2440

(3004789) Transferrin [Mass/volume] in Serum or Plasma

308

1661

2.13

26.85

2.6

2.4

g/l

2.3

0.63

282

1527

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

786

5837

1.93

26.83

5.6

6.1

umol/l

10.4

11.7

2.13

752

5513

(3002582) Erythrocytes [#/volume] in Urine

531

3474

1.92

26.75

3.9

3.3

e6/l

31.6

76.4

1.49

442

2689

(3024561) Albumin [Mass/volume] in Serum or Plasma

707

5077

1.90

26.69

5.0

4.5

g/l

33.5

34.8

7.32

660

4689

(36304419) Bacteria [Presence] in Urine

483

3073

1.93

26.38

3.7

3.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

6.65

26.12

1.2

1.3

g/l

0.3

0.4

0.66

(3028192) IgG subclass 2 [Mass/volume] in Serum

6.65

26.12

1.2

1.3

g/l

2.8

2.7

0.06

(3027135) IgG subclass 1 [Mass/volume] in Serum

6.65

26.12

1.2

1.3

g/l

6.1

7.3

0.76

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

133

4.69

25.43

1.6

1.5

52.2

68.2

1.93

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

289

1562

2.11

24.82

2.7

2.4

20.1

21.5

0.88

247

1322

(3026493) Urate [Moles/volume] in Serum or Plasma

436

2725

1.92

24.79

2.9

2.8

umol/l

4081.9

8320.8

1.26

377

2294

(40768804) Tissue Pathology biopsy report

609

4235

1.85

24.76

2.3

2.2

—

(3021788) Differential panel - Synovial fluid

208

3.83

24.43

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

186

3.99

24.26

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

143

4.43

24.13

1.5

1.1

u/ml

64.8

13.9

—

(4062490)

6.20

23.85

1.2

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

219

3.68

23.42

1.2

mmol/l

3.8

0.34

208

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

513

3427

1.84

23.35

2.7

2.4

u/l

58.7

57.6

0.11

474

3122

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

131

4.51

23.11

1.5

2.8

u/ml

165.0

2446.5

—

(3008898) HLA-B27 [Presence]

199

3.78

22.82

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

14.22

22.82

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

14.22

22.82

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

14.22

22.82

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

14.22

22.82

1.1

—

(3026782) Osmolality of Urine

380

2322

1.91

22.78

3.3

2.8

mosm/kgh2o

509.0

540.3

2.47

322

1963

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

311

3.19

22.57

1.5

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

394

2447

1.89

22.40

3.1

2.6

e6/l

5.0

5.6

0.48

351

2150

(3027945) Reticulocytes/100 erythrocytes in Blood

264

1433

2.07

22.16

2.3

2.5

1.9

1.8

0.26

239

1254

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

249

3.41

21.90

1.2

1.3

mg/l

469.3

515.1

0.48

235

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

259

1405

2.06

21.74

2.1

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1151

10105

2.71

21.70

35.7

16.2

mg/l

23.6

26.1

2.20

1088

8182

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

179

846

2.30

21.25

1.7

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

9.43

20.91

1.1

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

6.96

20.86

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

6.96

20.86

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

6.96

20.86

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

107

399

2.84

20.81

1.9

2.3

ug/l

283.9

528.4

0.85

377

(3032080) INR in Blood by Coagulation assay

663

4898

1.75

20.59

9.9

10.5

inr

1.3

0.45

185

1324

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

256

1410

2.03

20.50

2.1

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

623

4527

1.75

20.48

5.7

4.0

ng/l

29.7

52.4

2.17

496

3453

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

6.82

20.47

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

6.82

20.47

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

6.82

20.47

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

556

3923

1.75

20.19

3.4

3.0

ng/l

1542.7

1623.7

0.16

497

3375

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

671

5001

1.74

19.95

2.3

2.1

pmol/l

90.9

93.9

0.93

367

2477

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

182

3.65

19.47

4.3

3.0

63.5

60.1

1.13

182

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

5.07

19.33

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

207

1080

2.10

19.10

2.4

2.5

e9/l

70.8

69.1

0.24

160

838

(3048689) Calprotectin [Mass/mass] in Stool

194

992

2.13

18.86

2.2

1.9

ug/g

255.5

146.8

1.30

159

769

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.33

18.52

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

389

2526

1.78

18.49

5.8

4.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

181

3.55

18.15

2.6

4.0

0.7

1.6

1.39

144

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

4.69

18.07

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

291

1741

1.87

18.02

2.0

1.9

29.3

29.7

0.35

283

1678

(3030905) Polymorphonuclear cells [#/volume] in Blood

173

3.59

17.89

4.1

2.8

e9/l

5.2

4.5

1.24

173

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

145

3.85

17.84

1.3

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.84

17.64

1.1

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

385

2523

1.76

17.57

2.0

1.8

nmol/l

1140.1

1189.7

0.47

287

1837

(40768797) Stomach Pathology biopsy report

259

1503

1.91

17.57

1.3

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

349

2224

1.79

17.53

1.9

1.6

mg/l

1.4

0.01

279

1750

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

4.66

17.12

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

273

2.98

17.00

1.7

e6/l

10348.1

17726.3

1.20

200

(3007566) Smooth muscle Ab [Titer] in Serum

215

3.24

16.92

1.3

1.1

titre

70.0

74.2

—

(3029937) Albumin [Presence] in Urine by Test strip

418

2828

1.72

16.90

7.2

4.5

estimate

0.0

0.50

182

898

(3016018) Differential panel - Cerebral spinal fluid

4.61

16.89

1.1

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

556

4061

1.66

16.81

3.2

3.5

mmol/l

2.3

2.4

1.67

465

3464

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

128

582

2.34

16.49

1.5

1.7

g/l

2.1

1.6

5.39

109

502

(3017704) Immunofixation for Urine

5.04

16.47

1.4

2.0

—

(3026008) Bacteria identified in Urine by Culture

543

3967

1.65

16.23

3.9

3.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

216

1226

1.92

15.52

2.1

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

127

3.81

15.41

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.49

14.79

1.2

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

175

3.30

14.77

1.2

—

(3019225) pH of Specimen

211

1217

1.88

14.36

5.8

4.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

310

2007

1.72

14.32

3.2

2.8

e6/l

2.0

1.2

0.32

201

1158

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

179

3.23

14.25

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

206

3.06

14.17

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

4.62

14.05

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

624

4831

1.58

13.97

2.8

2.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

104

3.94

13.85

1.1

1.3

—

(3045424) Erythrocytes [Presence] in Urine

157

3.34

13.79

1.5

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

300

2.67

13.77

1.1

1.4

—

(3045414) Leukocytes [Presence] in Urine

104

468

2.33

13.70

2.3

2.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

101

3.95

13.58

1.2

u/l

46.3

55.1

0.95

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

5.51

13.57

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

5.40

13.28

1.1

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

919

7846

1.64

13.17

4.6

4.1

pmol/l

15.3

15.1

2.07

835

6955

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

196

1134

1.86

13.15

3.2

2.5

ug/l

5.0

6.5

1.17

161

981

(3012095) Magnesium [Moles/volume] in Serum or Plasma

283

1829

1.71

13.01

2.6

3.0

mmol/l

0.8

0.06

257

1688

(3008757) Leukocyte morphology finding [Identifier] in Blood

138

3.42

12.96

2.9

4.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

176

992

1.90

12.78

4.4

3.7

mmol/l

1.2

1.47

164

850

(3017354) Segmented neutrophils/100 leukocytes in Blood

115

3.65

12.77

2.7

3.4

59.0

56.9

0.21

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

286

1869

1.69

12.57

3.5

2.9

e6/l

4.6

2.6

1.38

176

1028

(3033658) Prothrombin time (PT) actual/Normal

388

2739

1.60

12.55

4.2

3.9

90.5

86.7

2.17

381

2672

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

222

2.84

12.43

1.2

1.3

e6/l

2141.2

764.1

0.30

185

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

222

2.84

12.43

1.2

e6/l

26.2

45.0

0.26

178

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

520

3934

1.55

12.41

6.9

4.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

132

3.42

12.40

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

350

2419

1.62

12.32

2.8

3.1

mmol/l

2.5

0.40

300

2128

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

259

2.68

12.18

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

259

2.68

12.18

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

334

2298

1.62

11.91

5.9

4.0

ng/l

109.0

318.6

3.61

284

1959

(40761535) Cells panel - Urine sediment

171

981

1.86

11.72

5.4

3.6

—

(3044927) Protein electrophoresis panel - Urine

134

3.29

11.44

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

5.96

11.35

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

238

1521

1.70

11.25

5.8

4.9

mmol/l

1.1

1.0

0.68

220

1383

(3014111) Lactate [Moles/volume] in Serum or Plasma

173

1018

1.81

10.90

6.2

mmol/l

1.4

0.20

163

986

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

6.01

10.88

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

6.01

10.88

1.1

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

124

3.30

10.74

1.2

u/ml

290.0

316.3

0.17

(3023410) Appearance of Cerebral spinal fluid

3.61

10.52

1.5

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

455

2.15

10.40

2.1

1.8

—

(3000494) Fungus identified in Specimen by Culture

196

1215

1.73

10.30

1.6

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

187

2.80

10.28

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

182

1112

1.74

10.06

1.4

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

166

990

1.78

9.97

3.4

3.5

ng/l

93.1

91.6

0.06

149

824

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

119

639

1.95

9.94

2.6

2.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

166

992

1.78

9.90

2.4

2.3

u/l

29.3

36.0

1.56

139

825

(3041096) Erythrocytes [Presence] in Urine by Automated

365

2657

1.53

9.89

5.9

4.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

404

3011

1.50

9.77

1.7

1.6

nmol/l

19.2

20.7

1.33

350

2489

(3011412) CD3 cells [#/volume] in Blood

3.78

9.63

2.2

1.8

e9/l

1.4

1.0

1.02

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1041

9401

1.63

9.55

5.9

5.0

mu/l

1.8

2.2

1.79

957

8376

(3014148) Varicella zoster virus Ab [Titer] in Serum

4.16

9.46

1.1

—

(3042936) Bacteria identified in Isolate by Culture

244

1638

1.61

9.38

2.1

2.0

—

(40761511) CBC panel - Blood by Automated count

1124

10372

1.81

9.37

26.8

15.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

7.07

9.30

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

186

2.70

9.28

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

110

3.24

9.22

1.4

1.6

—

(3025941) Bacteria identified in Stool by Culture

512

2.01

9.20

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1062

9666

1.65

9.11

7.5

6.5

mmol/mol

41.2

40.8

0.71

987

8748

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

132

3.02

9.10

3.8

3.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

411

2.12

9.06

2.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

124

697

1.86

9.02

1.6

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

165

1012

1.73

8.96

6.9

6.3

mmol/l

10.6

10.7

0.11

158

958

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

297

2.29

8.74

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

247

1689

1.58

8.74

37.9

29.1

inr

1.3

1.4

0.30

209

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

3.29

8.66

1.4

31.0

28.4

0.14

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

136

2.93

8.65

1.1

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

299

2.27

8.61

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

143

2.86

8.49

1.6

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

166

2.71

8.45

1.6

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

4.34

8.42

1.2

1.3

7.7

2.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

302

2.25

8.41

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

144

2.84

8.38

1.1

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

495

1.97

8.32

2.4

1.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

135

799

1.77

8.30

1.9

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1149

10737

1.84

8.29

30.3

19.6

mmol/l

139.3

139.6

2.36

1132

10438

(3005322) IgE [Units/volume] in Serum or Plasma

504

1.96

8.23

1.3

1.2

u/ml

159.6

222.7

0.47

455

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

198

2.53

8.22

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

103

3.16

8.14

1.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

4.58

8.13

1.1

—

73.4

—

(3002385) Erythrocyte distribution width [Ratio]

912

8095

1.47

8.10

35.5

20.3

14.3

13.9

11.93

896

7896

(36660697) Celiac disease serology panel - Serum

119

684

1.82

8.06

1.3

1.2

—

(3002032) Base excess in Venous blood by calculation

176

1131

1.65

8.00

4.0

3.4

mmol/l

1.8

1.9

0.15

151

902

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

5.22

7.94

1.1

ratio

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

3.52

7.84

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

704

5983

1.40

7.84

3.8

3.1

u/l

52.3

52.7

0.04

659

5405

(3023103) Potassium [Moles/volume] in Serum or Plasma

1148

10754

1.81

7.80

30.7

19.8

mmol/l

4.0

2.73

1127

10440

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.24

7.72

1.2

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

273

1965

1.50

7.54

1.4

1.2

u/ml

1.2

1.4

0.23

492

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

265

2.25

7.45

1.8

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

148

2.69

7.44

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

131

2.80

7.43

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

104

3.03

7.38

1.5

1.7

—

(3022145) Colonoscopy Study observation

176

1155

1.61

7.34

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

174

1139

1.61

7.33

4.0

3.4

kpa

5.8

0.25

168

1106

(3047007) Chlamydophila sp Ab [Presence] in Serum

3.13

7.31

1.2

—

(3017732) Neutrophils [#/volume] in Blood

112

652

1.79

7.28

3.8

3.1

e9/l

4.6

4.0

1.33

477

(3049717) Cytology report of Urine Cyto stain

483

1.91

7.23

2.8

2.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1141

10705

1.74

7.23

21.4

11.1

u/l

23.3

24.1

1.40

1120

10225

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

7.75

7.12

1.4

1.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

399

3125

1.41

6.95

2.9

3.1

u/l

31.1

34.2

1.02

378

2960

(3000991) Gas panel - Venous blood

150

961

1.64

6.89

7.4

7.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

323

2.07

6.78

1.7

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

330

2.06

6.78

1.5

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

16.79

6.75

1.1

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

7.19

6.70

1.2

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

348

2.01

6.56

4.8

3.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

253

2.19

6.56

1.9

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

106

2.88

6.55

1.5

1.3

e6/l

18664.5

178352.2

1.04

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

5.24

6.49

1.5

1.4

ug/l

0.2

0.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.24

6.49

1.9

1.5

—

(3037121) Protein [Mass/volume] in Urine

392

1.94

6.48

2.1

2.9

g/l

0.3

0.24

140

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

3.96

6.45

1.3

1.1

u/l

1.0

1.2

1.64

(3004716) Salmonella sp identified in Stool by Organism specific culture

400

1.93

6.44

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

125

2.68

6.35

1.1

1.4

u/ml

110.1

107.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

176

1194

1.55

6.35

2.2

2.6

umol/l

6.7

8.8

0.79

156

1046

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1039

9602

1.48

6.30

25.3

15.7

ml/min/173m2

72.6

73.1

0.33

955

7926

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

103

2.86

6.29

1.2

1.1

u/ml

5.0

5.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

126

2.66

6.26

1.4

2.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.83

6.11

1.4

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

241

2.16

6.08

1.5

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.62

6.05

1.9

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.85

5.98

1.2

—

(3007461) Platelets [#/volume] in Blood

1159

11004

1.71

5.92

45.3

24.3

e9/l

263.3

245.8

13.72

1142

10668

(3000570) Elastase.pancreatic [Mass/mass] in Stool

319

1.99

5.92

1.3

1.4

ug/g

299.9

278.2

0.32

192

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1026

9489

1.45

5.90

4.5

4.2

mmol/l

1.3

0.04

922

8368

(3024731) MCV [Entitic volume]

1159

11005

1.71

5.90

45.1

24.2

92.0

91.6

1.71

1145

10791

(3035941) MCH [Entitic mass]

1159

11006

1.71

5.89

45.0

24.2

30.2

30.4

2.72

1145

10792

(3026361) Erythrocytes [#/volume] in Blood

1159

11006

1.71

5.89

45.3

24.3

e12/l

4.3

4.4

5.79

1140

10628

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

3.32

5.87

1.6

u/l

3.4

8.1

0.75

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

377

1.91

5.86

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

596

5073

1.33

5.85

4.3

4.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

1159

11009

1.70

5.84

45.6

24.5

g/l

128.9

132.0

11.46

1146

10794

(3010813) Leukocytes [#/volume] in Blood

1159

11009

1.70

5.84

45.3

24.3

e9/l

7.8

6.8

40.74

1141

10628

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

5.92

5.63

1.0

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

164

1129

1.52

5.52

3.4

2.9

ng/l

218.2

234.0

0.18

149

1037

(3026389) Candida sp identified in Specimen by Organism specific culture

147

2.42

5.50

1.3

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

558

1.72

5.49

3.0

3.1

pmol/l

4.3

4.4

0.05

478

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

455

1.79

5.37

4.7

4.0

mmol/l

25.0

25.1

0.16

418

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

4.15

5.36

1.2

1.1

—

(3013512) EKG study

433

3555

1.33

5.31

5.3

4.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

221

2.12

5.30

1.1

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

11.32

5.29

2.2

1.4

—

(3044941) Cell count panel - Synovial fluid

182

2.24

5.26

1.7

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

102

2.68

5.26

1.2

1.1

u/ml

4.9

6.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

144

2.40

5.26

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

193

1389

1.46

5.22

6.9

6.4

kpa

5.0

5.1

1.24

183

1317

(3027801) Oxygen [Partial pressure] in Arterial blood

193

1390

1.46

5.20

6.9

6.4

kpa

12.2

12.0

0.15

182

1319

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

156

1078

1.51

5.16

2.0

g/l

0.2

1.74

138

1003

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1071

10048

1.45

5.12

5.9

5.1

mmol/l

5.9

6.1

3.49

976

8897

(3005988) Vibrio sp identified in Specimen by Organism specific culture

146

2.37

5.11

1.5

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.23

5.10

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.23

5.10

1.2

1.1

—

(3022313) Gas panel - Capillary blood

539

1.70

5.09

4.6

3.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

13.41

5.08

1.1

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1058

9908

1.44

5.07

5.1

4.8

mmol/l

4.5

0.04

964

8915

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.48

5.04

2.5

1.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

147

2.35

5.04

1.5

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

541

1.69

5.03

3.8

3.6

mmol/l

24.4

24.1

0.58

494

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1049

9813

1.42

5.02

5.1

4.7

mmol/l

1.6

1.5

4.20

948

8760

(4027681)

3.51

4.90

1.3

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

144

2.33

4.80

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.91

4.77

1.1

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

102

2.58

4.73

1.7

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

102

2.58

4.73

1.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

102

2.58

4.73

1.7

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

146

2.29

4.66

1.5

1.4

—

(3036489) Thrombin time

347

1.83

4.66

1.7

1.9

21.9

21.7

0.07

315

(3024354) Oxygen [Partial pressure] in Venous blood

139

958

1.51

4.66

3.4

2.7

kpa

4.7

4.4

0.71

133

929

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

192

2.12

4.65

1.9

1.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

114

753

1.57

4.64

8.5

8.0

0.6

0.7

0.11

114

745

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

227

2.02

4.60

1.7

iu/l

5.4

4.9

0.05

(3024522) Salmonella sp identified in Specimen by Organism specific culture

147

2.28

4.60

1.5

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

262

1.95

4.59

1.7

1.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

4.43

4.57

1.7

1.3

42.8

15.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.83

4.56

1.4

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

338

2732

1.32

4.50

2.6

2.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.18

4.49

1.1

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.18

4.49

1.1

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.62

4.49

1.2

—

(3003396) Base excess in Arterial blood by calculation

189

1393

1.42

4.48

6.9

6.5

mmol/l

1.0

1.2

0.35

154

1076

(3016502) Oxygen saturation in Arterial blood

170

1230

1.44

4.46

7.4

6.8

96.2

95.3

1.80

163

1177

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

105

688

1.57

4.43

4.4

3.6

mmol/l

1.5

2.1

0.80

519

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

110

729

1.56

4.42

4.5

3.6

kpa

5.1

5.2

0.62

672

(3017817) Protein [Mass] in Urine collected for unspecified duration

106

2.48

4.40

3.1

2.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.53

4.34

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.57

4.30

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.90

4.26

2.1

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

648

1.57

4.20

7.7

7.0

mmol/l

24.8

24.9

0.19

643

(3044889) 12 lead EKG panel

828

7552

1.28

4.17

4.9

4.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

3.01

4.13

2.1

1.8

14.8

16.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1075

10176

1.40

4.11

5.8

5.4

mmol/l

2.6

1.15

976

9111

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.73

4.10

1.5

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.04

4.06

1.1

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

112

762

1.52

4.01

8.7

7.8

1.4

1.3

0.38

112

753

(3009343) pH of Capillary blood

107

721

1.53

4.01

4.5

3.6

7.4

0.13

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

6.47

3.98

1.2

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

156

1135

1.43

3.98

7.9

7.2

g/l

118.9

119.2

0.07

151

1087

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

3.04

3.97

2.5

2.0

e9/l

0.2

0.70

(3044640) Blood type and Crossmatch panel - Blood

422

3563

1.28

3.96

2.8

2.5

—

(3051651) Icteric interference index of Serum or Plasma

2.74

3.93

2.4

3.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

344

1.75

3.92

3.5

3.3

nmol/l

0.9

0.8

0.26

271

(40768443) Skin Pathology biopsy report

499

1.62

3.90

1.4

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

123

860

1.48

3.87

3.3

2.8

ml/min/173m2

54.5

60.0

0.91

375

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

622

1.55

3.83

8.3

8.6

mmol/l

24.5

0.07

573

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.82

3.81

1.1

miu/ml

1499.7

1761.6

0.39

(3012501) Base excess in Blood by calculation

259

1.85

3.76

5.9

4.8

mmol/l

2.4

2.8

0.50

176

(3013290) Carbon dioxide [Partial pressure] in Blood

260

1.84

3.72

5.9

4.8

kpa

5.0

5.1

0.55

255

(3027315) Oxygen [Partial pressure] in Blood

260

1.84

3.72

5.9

4.8

kpa

8.5

8.3

0.22

255

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.70

3.67

1.0

2.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

351

1.71

3.67

1.7

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

204

1.94

3.66

3.2

2.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

3.13

3.65

1.9

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

212

1.92

3.61

1.5

—

(4010399)

112

780

1.48

3.60

1.5

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

151

2.08

3.53

1.7

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

5.32

3.51

1.0

1.2

—

(3019060) Gas panel - Arterial blood

115

810

1.46

3.50

4.8

4.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

2.72

3.50

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.57

3.48

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.36

3.48

1.0

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

132

2.15

3.47

1.4

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

126

2.17

3.43

1.4

1.2

nmol/l

—

(3020891) Body temperature

493

1.58

3.40

6.2

4.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

932

8715

1.27

3.37

31.1

18.2

37.6

38.3

0.92

555

5416

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

7.03

3.36

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.85

3.36

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.85

3.36

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

134

2.11

3.35

3.4

3.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

2.73

3.33

2.1

e6/l

804.9

630.5

0.32

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

2.60

3.22

2.4

2.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

420

1.60

3.21

2.9

2.4

u/ml

0.4

0.32

231

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

313

2606

1.27

3.20

1.8

pmol/l

26877969.1

20210657.2

0.09

253

2093

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.35

3.19

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.36

3.19

1.3

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.36

3.19

1.5

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

6.39

3.18

1.9

1.0

—

(3006462) Nitrate [Presence] in Urine

2.98

3.14

7.7

4.4

—

(4306422)

2.27

3.14

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.56

3.13

1.3

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

4.52

3.11

10.9

7.4

—

(44790048)

118

2.14

3.11

1.3

1.4

—

(44806118)

118

2.14

3.11

1.3

1.4

—

(44790049)

118

2.14

3.11

1.3

1.4

—

(44790047)

118

2.14

3.11

1.3

1.4

—

(40761536) Microorganisms panel - Urine sediment

121

881

1.41

3.10

5.8

4.4

—

(3028433) Virus identified in Specimen by Culture

3.26

3.06

1.1

1.3

—

(3024263) Appearance of Synovial fluid

2.60

3.05

1.4

1.5

—

(3019150) Specific gravity of Urine by Refractometry

283

2341

1.27

3.04

7.5

4.6

kg/l

1.0

1.04

357

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

5.86

3.02

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

113

2.15

3.01

1.2

1.7

—

(40768446) Kidney Pathology biopsy report

4.31

2.99

1.1

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

412

3562

1.23

2.99

3.1

mmol/l

6.8

0.09

335

2910

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.29

2.94

1.5

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

101

2.20

2.94

1.2

—

(3010421) pH of Blood

321

1.65

2.88

6.6

4.3

7.4

0.28

254

(3042631) Mycobacterium sp identified in Specimen

171

1.89

2.88

4.9

2.7

—

(3023419) Bacteria identified in Sputum by Culture

150

1.96

2.86

2.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

245

1.74

2.86

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.24

2.81

2.1

1.6

—

(1616796) Gas panel - Central venous blood

239

1.74

2.80

4.5

4.1

—

(3026480) Teichoate Ab [Titer] in Serum

8.36

2.75

1.0

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.38

2.73

1.1

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

5.02

2.73

1.4

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

167

1308

1.32

2.72

2.8

4.1

ug/l

8.4

21.8

1.05

139

1091

(4211845)

2.73

2.72

7.7

4.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

162

1264

1.32

2.71

4.6

3.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

112

2.07

2.68

1.2

1.4

pmol/l

590.3

278.1

0.76

(3012516) Albumin [Mass/volume] in Urine

404

3524

1.22

2.63

3.1

3.2

mg/l

253.3

313.6

0.12

252

2182

(4268621)

2.32

2.58

2.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

3.62

2.57

1.4

1.1

—

216.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

636

1.43

2.57

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.05

2.53

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

390

1.54

2.50

1.1

—

135.1

—

(3029075) Extractable nuclear Ab panel - Serum

3.48

2.48

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.83

2.46

1.3

2.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.47

2.45

2.1

1.5

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

5.02

2.40

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.35

2.39

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.43

2.37

2.1

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

118

1.97

2.36

2.0

1.6

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

3.23

2.31

1.0

1.1

—

17.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.87

2.30

1.3

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.24

2.28

2.1

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2.08

2.27

1.2

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.57

2.27

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

4.63

2.27

1.3

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

185

1507

1.27

2.25

12.3

7.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

180

1463

1.27

2.23

5.0

4.8

33.6

0.03

139

929

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.12

2.22

1.0

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

3.12

2.22

1.4

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.35

2.22

1.9

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.35

2.22

2.0

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.35

2.22

2.0

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.35

2.22

2.0

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

107

1.98

2.21

1.4

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.42

2.20

6.9

4.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

528

1.43

2.19

1.1

1.2

iu/ml

198.2

133.8

0.46

189

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.92

2.07

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.01

2.07

1.0

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

262

1.58

2.05

1.8

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.01

2.04

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.41

2.03

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

444

1.44

2.01

4.8

3.4

mmol/l

1.3

1.4

0.65

435

(3002619) Bacteria identified in Specimen by Culture

3.35

1.96

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.98

1.93

1.0

1.1

—

(3002256) Pathology report gross observation

167

1370

1.25

1.93

1.2

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.46

1.93

1.0

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

101

1.89

1.81

1.1

—

(3000492) Spirometry study

102

796

1.31

1.77

1.6

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

414

3731

1.16

1.75

3.9

mg/mmol

14.3

8.6

0.98

261

2281

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.34

1.75

10.3

7.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.51

1.74

1.0

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

266

1.52

1.73

2.9

2.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.86

1.71

1.6

1.5

umol/l

34.8

48.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.86

1.71

13.2

11.2

mmol/l

4.6

6.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.86

1.71

1.8

1.1

ng/l

92.3

86.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

392

1.42

1.69

1.3

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

204

1.58

1.66

2.6

1.9

mmol/l

1.7

1.6

0.35

198

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.58

1.61

1.2

1.6

—

(3045142) Bone marrow Pathology biopsy report

136

1.70

1.59

1.1

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

100

1.81

1.53

1.4

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.34

1.52

1.4

1.2

—

(3003181) Sodium [Moles/volume] in Urine

234

1.51

1.50

1.6

1.3

mmol/l

57.1

59.7

0.22

191

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

620

1.31

1.49

10.8

9.0

—

(3000012) Reticulocyte production index

2.01

1.49

2.1

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

347

3123

1.15

1.47

5.4

5.5

ug/l

5.3

3.1

0.38

299

2744

(3023511) Choriogonadotropin [Units/volume] in Urine

2.38

1.45

1.6

1.1

—

(21494755) Public health laboratory ask at order entry panel

364

0.62

1.44

1.3

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.13

1.44

1.2

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.98

1.43

1.4

2.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.18

1.40

2.4

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.18

1.40

2.3

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.18

1.40

2.3

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

111

1.72

1.39

1.2

1.4

—

(3024928) Oxygen saturation in Venous blood

255

1.46

1.39

1.8

2.5

—

(1761868) Lipid panel - Serum or Plasma

258

2901

0.86

1.36

3.0

3.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.95

1.36

1.0

—

(4133840)

2.95

1.36

1.0

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

159

1.58

1.35

2.7

2.4

mg/l

15.1

26.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.00

1.32

0.0

1.2

—

15.8

—

(40767503) Oxygen content in Capillary blood by calculation

253

1.44

1.25

3.0

2.6

15.3

15.8

0.31

119

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.41

1.24

1.3

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

2.23

1.24

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

418

1.33

1.21

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.17

1.21

3.6

2.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.75

1.19

1.1

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

310

2808

1.14

1.19

1.7

1.6

mmol/l

1.3

0.06

255

2299

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.31

1.18

1.2

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.06

1.15

1.6

1.2

—

(4035726)

121

1029

1.19

1.06

1.3

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.13

1.05

1.6

1.5

—

(4146454)

138

1.53

1.03

2.9

2.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

278

2524

1.13

1.03

4.6

4.7

20.2

21.6

0.93

137

1295

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.74

1.03

1.0

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

230

1.40

1.02

1.3

2.7

umol/l

25.0

36.0

3.71

186

(3051387) C reactive protein [Mass/volume] in Capillary blood

274

0.65

1.01

5.7

4.1

mg/l

36.1

27.6

0.52

178

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

308

1.34

1.01

1.6

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.01

1.00

1.0

—

(4094501)

257

1.37

0.99

1.2

1.1

—

(4281824)

135

0.52

0.98

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.1

—

1.9

—

(4015189)

1.95

0.97

1.4

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

771

1.21

0.96

1.5

1.7

1.6

0.62

633

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

466

0.74

0.95

1.5

1.8

—

(3014271) Vancomycin [Susceptibility]

1.70

0.95

3.8

3.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

305

0.68

0.95

1.4

—

(3047181) Lactate [Moles/volume] in Blood

356

1.30

0.94

5.8

5.9

mmol/l

1.2

1.3

0.58

310

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.94

0.84

1.8

1.2

pmol/l

16.0

15.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

257

1.33

0.83

2.4

2.8

mg/l

1.9

1.7

0.39

230

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.73

0.79

1.0

1.4

g/l

0.7

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.79

0.0

6.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.67

0.78

3.5

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.67

0.78

3.5

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

278

1.30

0.78

1.6

1.4

—

(3017569) Oxygen content in Arterial blood

1.70

0.76

1.6

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.70

0.75

1.0

1.1

—

(3004451) EKG impression Narrative

1.65

0.75

2.0

1.3

—

(44813793)

1.64

0.73

1.0

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

620

1.19

0.70

3.7

2.8

e6/l

0.2

0.4

1.01

604

(21494434) Karyotype in Bone marrow

118

1.45

0.69

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

248

1.30

0.69

1.1

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.86

0.68

1.0

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.79

0.66

1.0

3.5

187.8

157.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.73

0.64

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

271

2529

1.09

0.62

1.4

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

0.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

0.59

0.0

1.7

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

12.8

—

950.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

131

1.38

0.59

1.1

1.2

u/l

12.3

10.8

0.17

(3000330) Specific gravity of Urine by Test strip

660

1.16

0.59

4.4

4.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

195

1798

1.10

0.58

3.3

ug/l

0.6

0.8

3.96

143

1261

(3047189) Immunofixation for 24 hour Urine

1.46

0.56

1.1

1.7

—

(3048879) Bone marrow aspiration report

1.62

0.55

2.3

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

133

1.36

0.55

3.2

2.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

125

0.64

0.54

1.5

1.6

—

(3012441) Differential panel - Pleural fluid

142

1.34

0.54

1.4

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

535

1.17

0.53

2.0

2.2

nmol/l

12.8

12.4

0.11

457

(3011648) Oxygen content in Venous blood

0.60

0.52

1.8

1.4

8.3

10.8

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.50

0.51

2.0

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

290

1.21

0.48

2.0

2.4

ug/min

291.5

80.2

0.42

166

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.49

0.47

1.0

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

2.6

—

0.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.41

0.0

1.4

—

8.3

—

(3042733) HLA Ab [Presence] in Serum

0.00

0.41

0.0

5.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.47

0.40

1.6

2.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.41

0.39

3.5

2.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

466

1.14

0.39

2.6

3.2

u/ml

80.4

3150.4

0.82

400

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

133

1.28

0.38

1.9

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

214

0.79

0.38

2.3

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.35

0.38

1.0

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

290

1.18

0.37

3.6

3.1

mmol/l

24.1

25.5

0.88

243

(3025130) Human papilloma virus identified in Specimen

1.39

0.37

1.5

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.27

0.36

2.2

2.6

—

(40768806) Pleura Pathology biopsy report

153

1.25

0.35

1.5

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

154

1.24

0.34

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

1.33

0.33

1.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

183

1.21

0.32

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

110

1.28

0.31

1.0

—

(3022621) pH of Urine by Test strip

765

1.09

0.30

4.0

3.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.21

0.26

7.8

1.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

193

0.83

0.26

1.5

1.6

—

(40768441) Liver Pathology biopsy report

0.68

0.26

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

101

947

1.07

0.25

1.5

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

114

1.23

0.25

1.4

2.0

pmol/l

193.8

211.3

0.38

107

(4034850)

349

0.89

0.24

31.0

11.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

190

1.16

0.23

1.5

g/l

28.0

31.0

0.60

172

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.21

0.0

1.3

—

0.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

44.6

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

261

0.88

0.20

1.3

1.7

mg/l

5.6

4.4

0.18

199

(3023383) Lactate [Moles/volume] in Pleural fluid

1.23

0.20

1.2

1.3

mmol/l

3.6

3.1

—

(3003338) MCHC [Mass/volume]

791

7993

0.97

0.18

41.1

22.2

g/l

327.8

330.9

18.54

784

7923

(3021901) Oxygen saturation in Capillary blood

215

1.12

0.16

2.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

224

0.89

0.15

3.2

3.9

u/ml

30.6

41.1

0.46

219

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1.11

0.15

3.0

4.8

—

28.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

104

1.16

0.12

1.1

1.0

—

(40768795) Lymph node Pathology biopsy report

114

0.88

0.09

1.4

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.07

0.08

3.8

5.8

—

(3051593) INR in Capillary blood by Coagulation assay

0.78

0.08

1.0

13.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.08

0.08

1.9

4.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.05

0.08

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.86

0.07

1.5

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.86

0.07

1.2

1.1

—

(40768793) Breast Pathology biopsy report

296

0.94

0.07

1.6

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.86

0.07

1.1

1.3

—

(3035880) pH of Pleural fluid

0.87

0.07

1.6

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

1.07

0.07

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1.06

0.07

1.0

1.2

—

(3020491) Glucose [Moles/volume] in Blood

1.06

0.07

1.2

2.8

mmol/l

7.0

7.4

—

(3027008) Opiates [Presence] in Urine

1.06

0.07

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

128

1.09

0.06

1.9

2.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

132

0.91

0.06

1.1

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

130

1276

1.02

0.06

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

129

1.09

0.05

2.9

4.4

umol/l

275.8

351.1

—

111

(3033705) Calcium.ionized [Moles/volume] in Venous blood

188

1.06

0.05

1.8

2.6

—

(40768800) Prostate Pathology biopsy report

211

0.95

0.04

1.1

1.2

—

(4024509)

122

1.07

0.02

1.4

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

113

1.06

0.02

1.7

2.3

u/field

0.3

2.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

284

1.02

0.00

1.1

1.2

—

(1002224) Polysomnography panel

238

1.01

0.00

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

252

0.99

0.00

2.2

g/l

126.1

0.00

185

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

201

0.99

0.00

1.4

1.5

nmol/l

0.8

—

164

(1761482) Bacteria [#/volume] in Urine by Culture

373

0.99

0.00

5.3

5.2

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.0

1.0

—

(3027944) Amphetamines [Presence] in Urine

0.94

0.00

1.0

1.2

—

(3016879) Cocaine [Presence] in Urine

1.00

0.00

1.0

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.4

—

183.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

336.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.94

0.00

1.0

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.0

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.0

3.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.0

7.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.5

—

2.8

—

(3045788) Cell count panel - Pleural fluid

140

1.00

0.00

1.3

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.88

0.00

1.6

1.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.0

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.95

0.00

1.7

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

26.8

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

2.2

—

1.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

0.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.96

0.00

1.7

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.2

—

376.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_TEMPARTERIT and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_TEMPARTERIT	1.308 [1.18, 1.44]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.119

During the follow-up period (1.1.1998 — 31.12.2019), 1563 out of 4350 females with M13_TEMPARTERIT died.

Males

Parameter	HR [95% CI]	p-value
M13_TEMPARTERIT	1.385 [1.19, 1.61]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 789 out of 2033 males with M13_TEMPARTERIT died.

Mortality risk

Mortality risk for people of age

years, who have M13_TEMPARTERIT.

N-year risk	Females	Males
1	0.127%	0.275%
5	0.736%	1.533%
10	1.731%	3.506%
15	3.541%	6.783%
20	6.176%	11.54%

Relationships between endpoints

↥

Index endpoint: M13_TEMPARTERIT – Temporal arteritis

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Temporal arteritis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints